151 related articles for article (PubMed ID: 26233476)
1. CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors.
Unver N; Esendagli G; Yilmaz G; Guc D
Cytokine; 2015 Oct; 75(2):330-7. PubMed ID: 26233476
[TBL] [Abstract][Full Text] [Related]
2. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
3. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
[TBL] [Abstract][Full Text] [Related]
4. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
[TBL] [Abstract][Full Text] [Related]
5. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
[TBL] [Abstract][Full Text] [Related]
7. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
[TBL] [Abstract][Full Text] [Related]
8. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
Yin X; Yan X; Yang Q; Cao H; Liang H
Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-38 promotes tumor growth through regulation of CD8
Kinoshita F; Tagawa T; Akamine T; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Shimokawa M; Oda Y; Hoshino T; Mori M
Cancer Immunol Immunother; 2021 Jan; 70(1):123-135. PubMed ID: 32653939
[TBL] [Abstract][Full Text] [Related]
10. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma.
Wald O; Izhar U; Amir G; Avniel S; Bar-Shavit Y; Wald H; Weiss ID; Galun E; Peled A
J Immunol; 2006 Nov; 177(10):6983-90. PubMed ID: 17082613
[TBL] [Abstract][Full Text] [Related]
11. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.
Saijo Y; Tanaka M; Miki M; Usui K; Suzuki T; Maemondo M; Hong X; Tazawa R; Kikuchi T; Matsushima K; Nukiwa T
J Immunol; 2002 Jul; 169(1):469-75. PubMed ID: 12077278
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
[TBL] [Abstract][Full Text] [Related]
14. Roles of CXC chemokines and macrophages in the recruitment of inflammatory cells and tumor rejection induced by Fas/Apo-1 (CD95) ligand-expressing tumor.
Shimizu M; Yoshimoto T; Sato M; Morimoto J; Matsuzawa A; Takeda Y
Int J Cancer; 2005 May; 114(6):926-35. PubMed ID: 15645421
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
16. Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
Tang SJ; Ho MY; Cho HC; Lin YC; Sun GH; Chi KH; Wang YS; Jhou RS; Yang W; Sun KH
Int J Cancer; 2008 Dec; 123(12):2840-8. PubMed ID: 18814280
[TBL] [Abstract][Full Text] [Related]
17. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
Zhang M; Yan L; Kim JA
Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
[TBL] [Abstract][Full Text] [Related]
18. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
[TBL] [Abstract][Full Text] [Related]
19. Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells.
Barakat DJ; Suresh R; Barberi T; Pienta KJ; Simons BW; Friedman AD
PLoS One; 2018; 13(1):e0191188. PubMed ID: 29324844
[TBL] [Abstract][Full Text] [Related]
20. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
